Skip to main content

WATSON 409 Pill - yellow round, 10mm

Pill with imprint WATSON 409 is Yellow, Round and has been identified as Lisinopril 40 mg. It is supplied by Watson Pharmaceuticals.

Lisinopril is used in the treatment of Heart Attack; High Blood Pressure; Heart Failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 409

Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409 Front
Lisinopril 40 mg WATSON 409 Back
Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409

Lisinopril

Imprint
WATSON 409
Strength
40 mg
Color
Yellow
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, calcium phosphate dihydrate dibasic, FD&C Yellow No. 5, magnesium stearate, mannitol, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-0409 Watson Pharmaceuticals, Inc.
54868-4646 (Discontinued) Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.